SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Medical ImagingNuclear Medical

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2129357

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2129357

Radiation Dose Management Market by Function (Dose Monitoring, Benchmarking, Reporting, Radiation Management), Technology (AI ), Deployment, Modality (CT, PET, SPECT), Application (Onco), End User (Hospital) - Global Forecast to 2031

PUBLISHED:
PAGES: 489 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The radiation dose management market is projected to reach USD 0.96 billion by 2031 from USD 0.51 billion in 2026, at a CAGR of 13.3% from 2026 to 2031. The market is experiencing steady growth owing to the increasing utilization of medical imaging procedures, rising focus on patient radiation safety, regulatory emphasis on radiation dose monitoring and optimization, and growing adoption of automated dose management systems.

Scope of the Report
Years Considered for the Study2026-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD billion)
SegmentsOffering, Function, Technology Deployment Model, Revenue Model, Modality, Application, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

The increasing volume and complexity of imaging procedures are accelerating the use of RDM systems across hospitals, healthcare systems, diagnostic and imaging centers, and other imaging facilities. These systems enable healthcare organizations to collect, monitor, archive, analyze, and share patient radiation dose data; identify dose variations; compare radiation exposure across facilities and procedures; support diagnostic reference levels (DRLs); and optimize imaging practices.

Radiation Dose Management Market - IMG1

"By offering, solutions accounted for the dominant share of the radiation dose management market in 2025."

Based on offering, the radiation dose management market is segmented into solutions and services. The solutions segment accounted for the dominant share of the market in 2025, driven by the increasing adoption of software platforms that automate radiation-dose data collection, monitoring, analysis, reporting, benchmarking, and optimization across medical imaging environments. RDM solutions enable healthcare organizations to collect and analyze dose information from multiple imaging modalities, identify dose variations and outliers, compare radiation exposure against diagnostic reference levels (DRLs), and support imaging-protocol optimization. The solutions segment is also benefiting from the shift from standalone dose-tracking tools toward integrated and interoperable dose-management platforms that connect imaging modalities with PACS, RIS, hospital information systems, and other healthcare IT infrastructure. The continued adoption of automated alerts, dose analytics, patient dose tracking, and advanced optimization capabilities is expected to support demand for RDM solutions throughout the forecast period.

"By deployment model, the cloud-based deployment is expected to witness high growth during the forecast period."

Based on deployment model, the radiation dose management market is segmented into on-premises and cloud-based/web-based deployment. The cloud-based/web-based deployment segment is expected to register higher CAGR during the forecast period, supported by the increasing need for centralized and remotely accessible dose-management systems across hospitals, diagnostic and imaging centers, and multi-site healthcare networks. Cloud-based and web-based RDM platforms allow healthcare organizations to access dose information across facilities, support centralized monitoring and benchmarking, and reduce the need for extensive on-site infrastructure. The adoption of these deployment models is further supported by the growing need to integrate dose data with PACS, RIS, and other healthcare information systems.

"North America accounted for the largest share of the radiation dose management market in 2025."

The radiation dose management market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the market in 2025, supported by well-established healthcare infrastructure, high adoption of advanced medical imaging technologies, large imaging volumes, and increasing emphasis on radiation safety and dose optimization. The US and Canada have mature healthcare systems with widespread use of CT, fluoroscopy, and interventional imaging, radiography, mammography, and nuclear medicine, creating strong demand for technologies that monitor and manage radiation exposure. Healthcare organizations across the region are increasingly adopting RDM solutions to automate dose monitoring, identify dose variations, benchmark radiation exposure, and support imaging protocol optimization. The presence of established RDM providers and a mature healthcare IT ecosystem further supports adoption of dose management technologies across hospitals, healthcare systems, and diagnostic imaging facilities. The continued expansion of advanced imaging and growing focus on patient safety and efficient dose management are expected to sustain North America's leading position in the RDM market during the forecast period.

The breakdown of primary interview participants is as mentioned below:

  • By Company Type: Tier 1 - 45%, Tier 2 - 35%, and Tier 3 - 20%
  • By Designation: C-level Executives - 26%, Directors - 17%, and Others - 57%
  • By Region: North America - 40%, Europe - 20%, Asia Pacific - 30%, Latin America- 6%, and Middle East - 4%

Bayer AG (Germany) and GE HealthCare (US) are among the key players in the radiation dose management market.

  • The study includes an in-depth competitive analysis of these key players in the radiation dose management market, with their company profiles, recent developments, and key market strategies.

Research Coverage

The report analyzes the radiation dose management market. It aims to estimate the market size and future growth potential of various market segments based on offering, function, technology, deployment model, revenue model, modality, application, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the radiation dose management market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

  • Analysis of key drivers (increasing utilization and complexity of imaging procedures, increasing regulatory emphasis on dose monitoring, optimization, and reference levels, growing concerns regarding radiation exposure and dose optimization), restraints (high implementation, integration, and maintenance costs, shortage of skilled professionals for radiation dose management and optimization), opportunities (increasing adoption of AI-enabled radiation dose optimization, growing adoption of vendor-neutral and cloud-based dose management platforms, increasing focus on age-specific radiation dose optimization), and challenges (lack of standardized and interoperable dose data across modalities and systems, variability in dose benchmarks and imaging protocols across institutions) influencing the growth of the radiation dose management market
  • Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and new product & service launches in the radiation dose management market
  • Market Development: Comprehensive information about lucrative markets (the report analyzes the radiation dose management market across varied regions)
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the radiation dose management market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Bayer AG (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Sectra AB (Sweden), and FUJIFILM Holdings Corporation (Japan)
Show more
Product Code: HIT 3247

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS SHAPING MARKET
  • 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
  • 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 RADIATION DOSE MANAGEMENT MARKET OVERVIEW
  • 3.2 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING AND COUNTRY
  • 3.3 RADIATION DOSE MANAGEMENT MARKET: REGIONAL GROWTH OPPORTUNITIES

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Increasing utilization and complexity of imaging procedures
      • 4.2.1.2 Increasing regulatory emphasis on dose monitoring, optimization, and reference levels
      • 4.2.1.3 Growing concerns regarding radiation exposure and dose optimization
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 High implementation and integration costs
      • 4.2.2.2 Shortage of skilled professionals for radiation dose management and optimization
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Increasing adoption of AI-enabled radiation dose optimization
      • 4.2.3.2 Growing adoption of vendor-neutral and cloud-based dose management platforms
      • 4.2.3.3 Increasing focus on age-specific radiation dose optimization
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Lack of standardized and interoperable dose data across modalities and systems
      • 4.2.4.2 Variability in dose benchmarks and imaging protocols across institutions
  • 4.3 UNMET NEEDS AND WHITE SPACES
  • 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 THREAT OF SUBSTITUTES
    • 5.1.3 BARGAINING POWER OF SUPPLIERS
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS AND FORECAST
    • 5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
  • 5.3 VALUE CHAIN ANALYSIS
    • 5.3.1 RESEARCH & PRODUCT DEVELOPMENT
    • 5.3.2 DATA & KNOWLEDGE ASSETS
    • 5.3.3 SOFTWARE & PLATFORM INFRASTRUCTURE
    • 5.3.4 CLOUD SERVICE PROVIDERS
    • 5.3.5 MARKETING & SALES
    • 5.3.6 POST-SALES SERVICES
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 PRICING ANALYSIS
    • 5.5.1 INDICATIVE PRICE FOR RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT (2025)
    • 5.5.2 INDICATIVE PRICE FOR RADIATION DOSE MANAGEMENT MARKET, BY REGION (2025)
  • 5.6 KEY CONFERENCES AND EVENTS
  • 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.8 INVESTMENT AND FUNDING SCENARIO
  • 5.9 CASE STUDY ANALYSIS
    • 5.9.1 REDUCING CT DOSE THROUGH REAL-TIME DOSE MONITORING AND ALERTING
    • 5.9.2 ESTABLISHING ENTERPRISE-WIDE, MULTI-MODALITY DOSE MANAGEMENT
    • 5.9.3 REDUCED RADIATION DOSE IN SPECIALIST CANCER CARE
    • 5.9.4 IMPROVED CARE COORDINATION
  • 5.10 IMPACT OF US TARIFF OVERVIEW
    • 5.10.1 INTRODUCTION
    • 5.10.2 KEY TARIFF RATES
  • 5.11 PRICE IMPACT ANALYSIS
  • 5.12 IMPACT ON COUNTRY/REGION
    • 5.12.1 US
    • 5.12.2 EUROPE
    • 5.12.3 ASIA PACIFIC
  • 5.13 IMPACT ON END USERS
    • 5.13.1 HOSPITALS AND HEALTHCARE SYSTEMS
    • 5.13.2 DIAGNOSTIC AND IMAGING CENTERS
    • 5.13.3 AMBULATORY SURGERY CENTERS
    • 5.13.4 OTHER END USERS

6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION

  • 6.1 KEY EMERGING TECHNOLOGIES
    • 6.1.1 AI-ENABLED RADIATION DOSE PREDICTION, MONITORING, AND OPTIMIZATION
    • 6.1.2 PATIENT-SPECIFIC AND PERSONALIZED DOSIMETRY TECHNOLOGIES
    • 6.1.3 ADVANCED IMAGING TECHNOLOGIES FOR RADIATION DOSE OPTIMIZATION
  • 6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.2.1 DICOM, RADIATION DOSE STRUCTURED REPORTS (RDSR), AND INTEROPERABILITY TECHNOLOGIES
    • 6.2.2 CLOUD-BASED, VENDOR-NEUTRAL, AND ENTERPRISE DOSE MANAGEMENT ARCHITECTURES
    • 6.2.3 DOSE REGISTRIES, BENCHMARKING, AND POPULATION-LEVEL DOSE ANALYTICS
  • 6.3 ADJACENT TECHNOLOGIES
    • 6.3.1 COMPUTATIONAL DOSIMETRY AND PATIENT-SPECIFIC DOSE MODELING
  • 6.4 TECHNOLOGY/PRODUCT ROADMAP
  • 6.5 PATENT ANALYSIS
    • 6.5.1 PATENT PUBLICATION TRENDS FOR RADIATION DOSE MANAGEMENT
    • 6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 6.6 FUTURE APPLICATIONS
    • 6.6.1 AI-ASSISTED PERSONALIZED RADIATION DOSE MANAGEMENT
    • 6.6.2 REAL-TIME DOSE OPTIMIZATION AND INTELLIGENT IMAGING WORKFLOW AUTOMATION
    • 6.6.3 LONGITUDINAL RADIATION-EXPOSURE MANAGEMENT AND PREDICTIVE DOSE ANALYTICS
  • 6.7 IMPACT OF AI/GEN AI ON RADIATION DOSE MANAGEMENT MARKET
    • 6.7.1 INTRODUCTION
    • 6.7.2 POTENTIAL OF AI/GEN AI IN RADIATION DOSE MANAGEMENT MARKET
    • 6.7.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION
    • 6.7.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
    • 6.7.5 MEDICAL IMAGING EQUIPMENT & IMAGING INFORMATICS
    • 6.7.6 DOSE REGISTRIES, BENCHMARKING & QUALITY MANAGEMENT
    • 6.7.7 AI-ENABLED IMAGING & CLINICAL WORKFLOW
    • 6.7.8 USER READINESS AND IMPACT ASSESSMENT
      • 6.7.8.1 User readiness
        • 6.7.8.1.1 User A: Hospitals & integrated health systems
        • 6.7.8.1.2 User B: Practices outpatient diagnostic imaging centers & radiology practices
        • 6.7.8.1.3 User C: Interventional radiology & cardiology centers
      • 6.7.8.2 Impact assessment
        • 6.7.8.2.1 User A: Hospitals & integrated health systems
          • 6.7.8.2.1.1 Implementation
          • 6.7.8.2.1.2 Impact
        • 6.7.8.2.2 User B: Outpatient diagnostic imaging centers & radiology practices
          • 6.7.8.2.2.1 Implementation
          • 6.7.8.2.2.2 Impact
        • 6.7.8.2.3 User C: Interventional radiology & cardiology centers
          • 6.7.8.2.3.1 Implementation
          • 6.7.8.2.3.2 Impact

7 REGULATORY LANDSCAPE

  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.2 REGULATORY FRAMEWORK
      • 7.1.2.1 North America
      • 7.1.2.2 Europe
      • 7.1.2.3 Asia Pacific
      • 7.1.2.4 Latin America
      • 7.1.2.5 Middle East & Africa
    • 7.1.3 INDUSTRY STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 8.1 INTRODUCTION
  • 8.2 DECISION-MAKING PROCESS
  • 8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
  • 8.4 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.4.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.4.2 BUYING CRITERIA
  • 8.5 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 8.6 UNMET NEEDS FROM VARIOUS END USERS
    • 8.6.1 UNMET NEEDS
    • 8.6.2 END USER EXPECTATIONS
  • 8.7 MARKET PROFITABILITY

9 RADIATION DOSE MANAGEMENT MARKET, BY OFFERING

  • 9.1 INTRODUCTION
  • 9.2 SOLUTIONS
    • 9.2.1 GROWING ADOPTION OF INTEGRATED AND AUTOMATED RADIATION DOSE MANAGEMENT SOLUTIONS TO DRIVE MARKET
    • 9.2.2 STANDALONE SOLUTIONS
      • 9.2.2.1 Growing demand for flexible and cost-effective dose monitoring solutions to boost market
    • 9.2.3 INTEGRATED SOLUTIONS
      • 9.2.3.1 Growing need for enterprise-wide, multi-vendor dose management to propel market
  • 9.3 SERVICES
    • 9.3.1 GROWING NEED FOR SPECIALIZED IMPLEMENTATION, CONSULTING, AND TRAINING EXPERTISE TO BOOST MARKET
    • 9.3.2 SUPPORT & MAINTENANCE SERVICES
      • 9.3.2.1 Growing need for continuous system availability and software updates to boost market
    • 9.3.3 IMPLEMENTATION & INTEGRATION SERVICES
      • 9.3.3.1 Growing hospital networks to drive demand for implementation and integration services
    • 9.3.4 CONSULTING SERVICES
      • 9.3.4.1 Growing need to interpret dose trends and identify outliers to drive segment
    • 9.3.5 EDUCATION & TRAINING SERVICES
      • 9.3.5.1 Increasing need for skilled personnel to support radiation dose optimization to boost segment

10 RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION

  • 10.1 INTRODUCTION
  • 10.2 DOSE TRACKING & MONITORING
    • 10.2.1 INCREASING ADOPTION OF AUTOMATED AND CONTINUOUS DOSE MONITORING
  • 10.3 DOSE ANALYTICS & BENCHMARKING
    • 10.3.1 GROWING NEED TO IDENTIFY DOSE OUTLIERS AND BENCHMARK IMAGING PERFORMANCE BOOSTS SEGMENT
  • 10.4 DOSE REPORTING & REGULATORY COMPLIANCE
    • 10.4.1 INCREASING REGULATORY EMPHASIS ON RADIATION DOSE DOCUMENTATION TO PROPEL SEGMENT
  • 10.5 PROTOCOL & DOSE OPTIMIZATION
    • 10.5.1 SEGMENT DRIVEN BY INCREASING FOCUS ON DOSE REDUCTION WHILE MAINTAINING DIAGNOSTIC IMAGE QUALITY
  • 10.6 PATIENT RADIATION EXPOSURE MANAGEMENT
    • 10.6.1 GROWING FOCUS ON PATIENT-SPECIFIC AND CUMULATIVE RADIATION EXPOSURE - KEY DRIVER
  • 10.7 OTHER FUNCTIONS
    • 10.7.1 INCREASING NEED FOR INTEROPERABILITY ACROSS HETEROGENEOUS IMAGING ENVIRONMENTS TO DRIVE SEGMENT

11 RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY

  • 11.1 INTRODUCTION
  • 11.2 AI-ENABLED TECHNOLOGY
    • 11.2.1 GROWING ADOPTION OF AI DRIVES SEGMENT GROWTH
    • 11.2.2 MACHINE LEARNING
      • 11.2.2.1 Growing adoption of predictive and patient-specific dose optimization to boost segment
    • 11.2.3 DEEP LEARNING
      • 11.2.3.1 Increasing use of deep learning for automated imaging and dose optimization
    • 11.2.4 COMPUTER VISION
      • 11.2.4.1 Increasing automation of image analysis and anatomical assessment to drive segment
    • 11.2.5 NATURAL LANGUAGE PROCESSING (NLP)
      • 11.2.5.1 Increasing availability of unstructured clinical data - key driver
  • 11.3 NON-AI/CONVENTIONAL TECHNOLOGY
    • 11.3.1 ESTABLISHED CLINICAL ADOPTION AND REGULATORY RELIABILITY

12 RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL

  • 12.1 INTRODUCTION
  • 12.2 ON-PREMISE DEPLOYMENT
    • 12.2.1 STRINGENT DATA-SECURITY POLICIES DRIVES SEGMENT GROWTH
  • 12.3 CLOUD-BASED/WEB-BASED DEPLOYMENT
    • 12.3.1 INCREASING NEED FOR SCALABLE, MULTI-SITE DOSE MONITORING AND REMOTE ACCESS TO IMAGING ANALYTICS BOOSTS DEMAND

13 RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL

  • 13.1 INTRODUCTION
  • 13.2 CAPITAL/ANNUAL PURCHASE MODEL
    • 13.2.1 ESTABLISHED PROCUREMENT PRACTICES DRIVE DEMAND
  • 13.3 PAY-PER-PROCEDURE MODEL
    • 13.3.1 AFFORDABILITY DRIVES SEGMENT GROWTH

14 RADIATION DOSE MANAGEMENT MARKET, BY MODALITY

  • 14.1 INTRODUCTION
  • 14.2 COMPUTED TOMOGRAPHY (CT)
    • 14.2.1 RAPID ADOPTION OF PHOTON-COUNTING CT AND AI-BASED RECONSTRUCTION TO DRIVE SEGMENT
  • 14.3 FLUOROSCOPY & INTERVENTIONAL IMAGING
    • 14.3.1 RISING PROCEDURAL COMPLEXITY INCREASES DEMAND FOR REAL-TIME RADIATION DOSE REDUCTION
  • 14.4 RADIOGRAPHY
    • 14.4.1 DIGITAL RADIOGRAPHY AND AI-BASED IMAGE ENHANCEMENT ENABLE LOWER EXPOSURE
  • 14.5 MAMMOGRAPHY
    • 14.5.1 EXPANSION OF 3D BREAST IMAGING DRIVES DEMAND
  • 14.6 NUCLEAR MEDICINE
    • 14.6.1 INCREASING USE OF HIGH-SENSITIVITY PET/SPECT AND AI-ENABLED RECONSTRUCTION TO DRIVE SEGMENT
    • 14.6.2 PET
      • 14.6.2.1 Higher PET sensitivity and AI reconstruction to boost demand
    • 14.6.3 SPECT
      • 14.6.3.1 Low-dose SPECT/CT technologies strengthen radiation optimization
    • 14.6.4 HYBRID
      • 14.6.4.1 Growing reliance on PET/CT and SPECT/CT drives market

15 RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION

  • 15.1 INTRODUCTION
  • 15.2 ONCOLOGY
    • 15.2.1 INCREASING FOCUS ON ONCOLOGY DRIVES DEMAND
  • 15.3 CARDIOLOGY
    • 15.3.1 INCREASING USE IN CARDIOLOGY BOOSTS DEMAND
  • 15.4 ORTHOPEDIC
    • 15.4.1 HIGH COMPLEXITY OF PROCEDURES DRIVES DEMAND
  • 15.5 DENTAL
    • 15.5.1 GROWING USE OF CBCT PROPELS DEMAND
  • 15.6 OTHER APPLICATIONS
    • 15.6.1 NEED TO MANAGE REPEATED EXAMINATIONS DRIVES DEMAND

16 RADIATION DOSE MANAGEMENT MARKET, BY END USER

  • 16.1 INTRODUCTION
  • 16.2 HOSPITALS & HEALTHCARE SYSTEMS
    • 16.2.1 DIVERSE IMAGING FLEETS DRIVE CENTRALIZED RDM AND PROTOCOL OPTIMIZATION ACROSS HOSPITAL NETWORKS
  • 16.3 DIAGNOSTIC & IMAGING CENTERS
    • 16.3.1 HIGH EXAMINATION VOLUMES AND MULTI-SITE IMAGING OPERATIONS ACCELERATE DEMAND
  • 16.4 AMBULATORY CARE SETTINGS
    • 16.4.1 EXPANSION OF OUTPATIENT AND AMBULATORY IMAGING INCREASES DEMAND
  • 16.5 ACADEMIC & RESEARCH INSTITUTES
    • 16.5.1 SEGMENT DRIVEN BY AI-DRIVEN LOW-DOSE IMAGING AND NEXT-GENERATION DOSE OPTIMIZATION TECHNOLOGIES
  • 16.6 OTHER END USERS
    • 16.6.1 REGULATORY OVERSIGHT, POPULATION-LEVEL RADIATION MONITORING, AND CLINICAL-TRIAL - KEY DRIVERS

17 RADIATION DOSE MANAGEMENT MARKET, BY REGION

  • 17.1 INTRODUCTION
  • 17.2 NORTH AMERICA
    • 17.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 17.2.2 US
      • 17.2.2.1 Regulatory focus on radiation safety drives market
    • 17.2.3 CANADA
      • 17.2.3.1 Increasing number of diagnostic imaging procedures to boost market
  • 17.3 EUROPE
    • 17.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 17.3.2 GERMANY
      • 17.3.2.1 Rising diagnostic imaging demand and aging population to drive market
    • 17.3.3 FRANCE
      • 17.3.3.1 Healthcare modernization to accelerate radiation dose management adoption
    • 17.3.4 UK
      • 17.3.4.1 Rising imaging volumes and NHS digitalization to support market growth
    • 17.3.5 ITALY
      • 17.3.5.1 Regulatory emphasis on dose optimization and monitoring to propel market
    • 17.3.6 SPAIN
      • 17.3.6.1 Growing focus on patient dosimetry and radiation dose optimization to drive market
    • 17.3.7 REST OF EUROPE
  • 17.4 ASIA PACIFIC
    • 17.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 17.4.2 CHINA
      • 17.4.2.1 Largest patient pool and increased healthcare spending to aid market growth
    • 17.4.3 JAPAN
      • 17.4.3.1 Large and technologically advanced hospital infrastructure
    • 17.4.4 INDIA
      • 17.4.4.1 Favorable government policies and improved healthcare infrastructure to support market growth
    • 17.4.5 AUSTRALIA
      • 17.4.5.1 Advancement of national diagnostic reference levels to accelerate radiation dose optimization
    • 17.4.6 SOUTH KOREA
      • 17.4.6.1 Increasing medical imaging volumes and patient radiation exposure to boost market
    • 17.4.7 REST OF ASIA PACIFIC
  • 17.5 LATIN AMERICA
    • 17.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 17.5.2 BRAZIL
      • 17.5.2.1 Increasing regulatory focus and adoption of advanced imaging technologies to drive market
    • 17.5.3 MEXICO
      • 17.5.3.1 Rising demand for diagnostic imaging and adoption of lower-dose technologies to support market growth
    • 17.5.4 REST OF LATIN AMERICA
  • 17.6 MIDDLE EAST & AFRICA
    • 17.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 17.6.2 GCC COUNTRIES
      • 17.6.2.1 Saudi Arabia
        • 17.6.2.1.1 Growing healthcare expenditure to boost market growth
      • 17.6.2.2 UAE
        • 17.6.2.2.1 Increasing healthcare infrastructure investments to drive market growth
      • 17.6.2.3 Rest of GCC
    • 17.6.3 SOUTH AFRICA
      • 17.6.3.1 Increasing focus on radiation dose optimization to propel market growth
    • 17.6.4 REST OF MIDDLE EAST & AFRICA

18 COMPETITIVE LANDSCAPE

  • 18.1 OVERVIEW
  • 18.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023-2026
  • 18.3 REVENUE ANALYSIS, 2021-2025
  • 18.4 MARKET SHARE ANALYSIS, 2021-2025
  • 18.5 BRAND COMPARISON
  • 18.6 COMPANY VALUATION AND FINANCIAL METRICS
  • 18.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 18.7.1 STARS
    • 18.7.2 EMERGING LEADERS
    • 18.7.3 PERVASIVE PLAYERS
    • 18.7.4 PARTICIPANTS
    • 18.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 18.7.5.1 Company footprint
      • 18.7.5.2 Region footprint
      • 18.7.5.3 Offering footprint
      • 18.7.5.4 Deployment model footprint
      • 18.7.5.5 Technology footprint
  • 18.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 18.8.1 PROGRESSIVE COMPANIES
    • 18.8.2 RESPONSIVE COMPANIES
    • 18.8.3 DYNAMIC COMPANIES
    • 18.8.4 STARTING BLOCKS
    • 18.8.5 COMPETITIVE BENCHMARKING STARTUPS/SMES, 2025
  • 18.9 COMPETITIVE SCENARIO
    • 18.9.1 DEALS
    • 18.9.2 OTHER DEVELOPMENTS

19 COMPANY PROFILES

  • 19.1 KEY PLAYERS
    • 19.1.1 BAYER AG
      • 19.1.1.1 Products/solutions/services offered
      • 19.1.1.2 Recent developments
        • 19.1.1.2.1 Product launches & upgrades
        • 19.1.1.2.2 Deals
        • 19.1.1.2.3 Other developments
      • 19.1.1.3 MnM view
        • 19.1.1.3.1 Key strengths
        • 19.1.1.3.2 Strategic choices
        • 19.1.1.3.3 Weaknesses and competitive threats
    • 19.1.2 SIEMENS HEALTHINEERS AG
      • 19.1.2.1 Business overview
      • 19.1.2.2 Products/solutions/services offered
      • 19.1.2.3 Recent developments
        • 19.1.2.3.1 Product launches & upgrades
        • 19.1.2.3.2 Deals
        • 19.1.2.3.3 Expansions
      • 19.1.2.4 MnM view
        • 19.1.2.4.1 Key strengths
        • 19.1.2.4.2 Strategic choices
        • 19.1.2.4.3 Weaknesses and competitive threats
    • 19.1.3 KONINKLIJKE PHILIPS N.V.
      • 19.1.3.1 Business overview
      • 19.1.3.2 Products/solutions/services offered
      • 19.1.3.3 Recent developments
        • 19.1.3.3.1 Product launches & upgrades
        • 19.1.3.3.2 Deals
      • 19.1.3.4 MnM view
        • 19.1.3.4.1 Key strengths
        • 19.1.3.4.2 Strategic choices
        • 19.1.3.4.3 Weaknesses and competitive threats
    • 19.1.4 GE HEALTHCARE
      • 19.1.4.1 Business overview
      • 19.1.4.2 Products/solutions/services offered
      • 19.1.4.3 Recent developments
        • 19.1.4.3.1 Product launches & upgrades
        • 19.1.4.3.2 Deals
        • 19.1.4.3.3 Other developments
      • 19.1.4.4 MnM view
        • 19.1.4.4.1 Key strengths
        • 19.1.4.4.2 Strategic choices
        • 19.1.4.4.3 Weaknesses and competitive threats
    • 19.1.5 FUJIFILM HOLDINGS CORPORATION
      • 19.1.5.1 Business overview
      • 19.1.5.2 Products/solutions/services offered
      • 19.1.5.3 Recent developments
        • 19.1.5.3.1 Product launches & upgrades
        • 19.1.5.3.2 Deals
        • 19.1.5.3.3 Other developments
      • 19.1.5.4 MnM view
        • 19.1.5.4.1 Key strengths
        • 19.1.5.4.2 Strategic choices
        • 19.1.5.4.3 Weaknesses and competitive threats
    • 19.1.6 SECTRA AB
      • 19.1.6.1 Business overview
      • 19.1.6.2 Products/solutions/services offered
      • 19.1.6.3 Recent developments
        • 19.1.6.3.1 Product launches & upgrades
        • 19.1.6.3.2 Deals
        • 19.1.6.3.3 Other developments
    • 19.1.7 CANON INC.
      • 19.1.7.1 Business overview
      • 19.1.7.2 Products/solutions/services offered
      • 19.1.7.3 Recent developments
        • 19.1.7.3.1 Product launches & upgrades
        • 19.1.7.3.2 Deals
        • 19.1.7.3.3 Other developments
    • 19.1.8 AGFA-GEVAERT N.V.
      • 19.1.8.1 Business overview
      • 19.1.8.2 Products/solutions/services offered
      • 19.1.8.3 Recent developments
        • 19.1.8.3.1 Product launches & upgrades
        • 19.1.8.3.2 Deals
    • 19.1.9 PACSHEALTH, LLC
      • 19.1.9.1 Business overview
      • 19.1.9.2 Products/solutions/services offered
      • 19.1.9.3 Recent developments
        • 19.1.9.3.1 Deals
    • 19.1.10 QAELUM
      • 19.1.10.1 Business overview
      • 19.1.10.2 Products/solutions/services offered
      • 19.1.10.3 Recent developments
        • 19.1.10.3.1 Deals
    • 19.1.11 MEDSQUARE
      • 19.1.11.1 Business overview
      • 19.1.11.2 Products/solutions/services offered
      • 19.1.11.3 Recent developments
        • 19.1.11.3.1 Product launches & upgrades
        • 19.1.11.3.2 Deals
    • 19.1.12 NOVARAD
      • 19.1.12.1 Business overview
      • 19.1.12.2 Products/solutions/services offered
    • 19.1.13 INFINITT HEALTHCARE CO., LTD.
      • 19.1.13.1 Business overview
      • 19.1.13.2 Products/solutions/services offered
    • 19.1.14 CARESTREAM HEALTH
      • 19.1.14.1 Business overview
      • 19.1.14.2 Products/solutions/services offered
      • 19.1.14.3 Recent developments
        • 19.1.14.3.1 Product Launches & upgrades
        • 19.1.14.3.2 Deals
    • 19.1.15 SHIMADZU CORPORATION
      • 19.1.15.1 Business overview
      • 19.1.15.2 Products/solutions/services offered
      • 19.1.15.3 Recent developments
        • 19.1.15.3.1 Products launches & upgrades
        • 19.1.15.3.2 Deals
    • 19.1.16 NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.
      • 19.1.16.1 Business overview
      • 19.1.16.2 Products/solutions/services offered
      • 19.1.16.3 Recent developments
        • 19.1.16.3.1 Product Launches & upgrades
        • 19.1.16.3.2 Deals
    • 19.1.17 NEUSOFT MEDICAL SYSTEMS CO., LTD.
      • 19.1.17.1 Business overview
      • 19.1.17.2 Products/solutions/services offered
      • 19.1.17.3 Recent developments
        • 19.1.17.3.1 Product launches & upgrades
        • 19.1.17.3.2 Deals
    • 19.1.18 KONICA MINOLTA, INC
      • 19.1.18.1 Business overview
      • 19.1.18.2 Products/solutions/services offered
      • 19.1.18.3 Recent developments
        • 19.1.18.3.1 Product Launches & upgrades
        • 19.1.18.3.2 Deals
    • 19.1.19 IBA
      • 19.1.19.1 Business overview
      • 19.1.19.2 Products/solutions/services offered
      • 19.1.19.3 Recent developments
        • 19.1.19.3.1 Product launches & upgrades
        • 19.1.19.3.2 Deals
    • 19.1.20 LUNIT INC.
      • 19.1.20.1 Business overview
      • 19.1.20.2 Products/solutions/services offered
      • 19.1.20.3 Recent developments
        • 19.1.20.3.1 Deals
  • 19.2 OTHER PLAYERS
    • 19.2.1 QIT SYSTEME GMBH
    • 19.2.2 IMALOGIX
    • 19.2.3 IDOSE
    • 19.2.4 MYXRAYDOSE LTD.
    • 19.2.5 VIRTUAL PHANTOMS INC.

20 RESEARCH METHODOLOGY

  • 20.1 RESEARCH APPROACH
    • 20.1.1 SECONDARY RESEARCH
      • 20.1.1.1 Key data from secondary sources
    • 20.1.2 PRIMARY RESEARCH
      • 20.1.2.1 Key data from primary sources
      • 20.1.2.2 Insights from primary experts
  • 20.2 RESEARCH METHODOLOGY
  • 20.3 MARKET SIZE ESTIMATION
  • 20.4 MARKET BREAKDOWN DATA TRIANGULATION
  • 20.5 MARKET SHARE ESTIMATION
  • 20.6 STUDY ASSUMPTIONS
  • 20.7 LIMITATIONS
    • 20.7.1 SCOPE-RELATED LIMITATIONS
    • 20.7.2 METHODOLOGY-RELATED LIMITATIONS
  • 20.8 RISK ASSESSMENT

21 APPENDIX

  • 21.1 DISCUSSION GUIDE
  • 21.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 21.3 CUSTOMIZATION OPTIONS
  • 21.4 RELATED REPORTS
  • 21.5 AUTHOR DETAILS
Show more
Product Code: HIT 3247

List of Tables

  • TABLE 1 EXCHANGE RATES FOR CONVERSION TO USD
  • TABLE 2 RADIATION DOSE MANAGEMENT MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 3 RADIATION DOSE MANAGEMENT MARKET: ROLE IN ECOSYSTEM
  • TABLE 4 INDICATIVE PRICE FOR RADIATION DOSE MANAGEMENT MARKET, BY OFFERING (2025)
  • TABLE 5 INDICATIVE PRICE FOR RADIATION DOSE MANAGEMENT MARKET, BY REGION (2025)
  • TABLE 6 RADIATION DOSE MANAGEMENT: KEY CONFERENCES AND EVENTS (2026-2027)
  • TABLE 7 CASE 1: REDUCING RADIATION DOSE THROUGH DOSE MONITORING AND ALERTS
  • TABLE 8 CASE 2: ESTABLISHING MULTI-MODALITY DOSE MANAGEMENT THROUGH RADIMETRICS
  • TABLE 9 CASE 3: REDUCING RADIATION DOSE THROUGH DOSE MANAGEMENT AND PROTOCOL OPTIMIZATION
  • TABLE 10 CASE 4: ASKLEPIOS CLINICS - ENTERPRISE-WIDE RADIATION DOSE MANAGEMENT
  • TABLE 11 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 12 TOP APPLICANT COUNTRIES FOR RADIATION DOSE MANAGEMENT MARKET
  • TABLE 13 RADIATION DOSE MANAGEMENT MARKET: KEY PATENTS
  • TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 REGULATORY SCENARIO IN NORTH AMERICA
  • TABLE 20 REGULATORY SCENARIO IN EUROPE
  • TABLE 21 REGULATORY SCENARIO IN ASIA PACIFIC
  • TABLE 22 REGULATORY SCENARIO IN LATIN AMERICA
  • TABLE 23 REGULATORY SCENARIO IN MIDDLE EAST & AFRICA
  • TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS (%)
  • TABLE 25 BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 26 UNMET NEEDS IN RADIATION DOSE MANAGEMENT MARKET
  • TABLE 27 END USER EXPECTATIONS IN RADIATION DOSE MANAGEMENT MARKET
  • TABLE 28 RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 29 SOLUTIONS OFFERED BY KEY MARKET PLAYERS
  • TABLE 30 RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 31 RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 32 KEY STANDALONE SOLUTIONS OFFERED BY MARKET PLAYERS
  • TABLE 33 RADIATION DOSE MANAGEMENT MARKET FOR STANDALONE SOLUTIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 34 KEY INTEGRATED SOLUTIONS OFFERED BY MARKET PLAYERS
  • TABLE 35 RADIATION DOSE MANAGEMENT MARKET FOR INTEGRATED SOLUTIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 36 SERVICES OFFERED BY KEY MARKET PLAYERS
  • TABLE 37 RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 38 RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 39 RADIATION DOSE MANAGEMENT MARKET FOR SUPPORT & MAINTENANCE SERVICES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 40 RADIATION DOSE MANAGEMENT MARKET FOR IMPLEMENTATION & INTEGRATION SERVICES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 41 RADIATION DOSE MANAGEMENT MARKET FOR CONSULTING SERVICES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 42 RADIATION DOSE MANAGEMENT MARKET FOR EDUCATION & TRAINING SERVICES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 43 RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 44 RADIATION DOSE MANAGEMENT MARKET FOR DOSE TRACKING & MONITORING, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 45 RADIATION DOSE MANAGEMENT MARKET FOR DOSE ANALYTICS & BENCHMARKING, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 46 RADIATION DOSE MANAGEMENT MARKET FOR DOSE REPORTING & REGULATORY COMPLIANCE, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 47 RADIATION DOSE MANAGEMENT MARKET FOR PROTOCOL & DOSE OPTIMIZATION, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 48 RADIATION DOSE MANAGEMENT MARKET FOR PATIENT RADIATION EXPOSURE MANAGEMENT, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 49 RADIATION DOSE MANAGEMENT MARKET FOR OTHER FUNCTIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 50 RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 51 RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 52 RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 53 RADIATION DOSE MANAGEMENT MARKET FOR MACHINE LEARNING, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 54 RADIATION DOSE MANAGEMENT MARKET FOR DEEP LEARNING, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 55 RADIATION DOSE MANAGEMENT MARKET FOR COMPUTER VISION, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 56 RADIATION DOSE MANAGEMENT MARKET FOR NATURAL LANGUAGE PROCESSING (NLP), BY REGION, 2024-2031 (USD MILLION)
  • TABLE 57 RADIATION DOSE MANAGEMENT MARKET FOR NON-AI/CONVENTIONAL TECHNOLOGY, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 58 RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 59 RADIATION DOSE MANAGEMENT MARKET FOR ON-PREMISE DEPLOYMENT, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 60 RADIATION DOSE MANAGEMENT MARKET FOR CLOUD-BASED/WEB-BASED DEPLOYMENT, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 61 RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 62 RADIATION DOSE MANAGEMENT MARKET FOR CAPITAL/ANNUAL PURCHASE MODEL, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 63 RADIATION DOSE MANAGEMENT MARKET FOR PAY-PER-PROCEDURE MODEL, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 64 RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 65 RADIATION DOSE MANAGEMENT MARKET FOR COMPUTED TOMOGRAPHY (CT), BY REGION, 2024-2031 (USD MILLION)
  • TABLE 66 RADIATION DOSE MANAGEMENT MARKET FOR FLUOROSCOPY & INTERVENTIONAL IMAGING, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 67 RADIATION DOSE MANAGEMENT MARKET FOR RADIOGRAPHY, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 68 RADIATION DOSE MANAGEMENT MARKET FOR MAMMOGRAPHY, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 69 RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 70 RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 71 RADIATION DOSE MANAGEMENT MARKET FOR PET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 72 RADIATION DOSE MANAGEMENT MARKET FOR SPECT, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 73 RADIATION DOSE MANAGEMENT MARKET FOR HYBRID, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 74 RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 75 RADIATION DOSE MANAGEMENT MARKET FOR ONCOLOGY, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 76 RADIATION DOSE MANAGEMENT MARKET FOR CARDIOLOGY, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 77 RADIATION DOSE MANAGEMENT MARKET FOR ORTHOPEDICS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 78 RADIATION DOSE MANAGEMENT MARKET FOR DENTAL, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 79 RADIATION DOSE MANAGEMENT MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 80 RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 81 RADIATION DOSE MANAGEMENT MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 82 RADIATION DOSE MANAGEMENT MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 83 RADIATION DOSE MANAGEMENT MARKET FOR AMBULATORY CARE SETTINGS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 84 RADIATION DOSE MANAGEMENT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 85 RADIATION DOSE MANAGEMENT MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 86 RADIATION DOSE MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 87 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 88 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 89 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 90 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 91 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 92 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 93 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 94 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 95 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 96 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 97 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 98 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 99 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 100 US: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 101 US: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 102 US: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 103 US: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 104 US: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 105 US: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 106 US: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 107 US: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 108 US: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 109 US: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 110 US: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 111 US: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 112 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 113 CANADA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 114 CANADA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 115 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 116 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 117 CANADA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 118 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 119 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 120 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 121 CANADA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 122 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 123 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 124 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 125 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 126 EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 127 EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 128 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 129 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 130 EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 131 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 132 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 133 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 134 EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 135 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 136 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 137 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 138 GERMANY: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 139 GERMANY: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 140 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 141 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 142 GERMANY: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 143 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 144 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 145 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 146 GERMANY: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 147 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 148 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 149 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 150 FRANCE: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 151 FRANCE: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 152 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 153 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 154 FRANCE: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 155 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 156 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 157 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 158 FRANCE: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 159 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 160 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 161 UK: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 162 UK: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 163 UK: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 164 UK: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 165 UK: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 166 UK: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 167 UK: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 168 UK: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 169 UK: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 170 UK: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 171 UK: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 172 UK: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 173 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 174 ITALY: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 175 ITALY: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 176 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 177 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 178 ITALY: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 179 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 180 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 181 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 182 ITALY: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 183 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 184 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 185 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 186 SPAIN: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 187 SPAIN: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 188 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 189 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 190 SPAIN: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 191 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 192 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 193 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 194 SPAIN: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 195 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 196 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 197 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 198 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 199 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 200 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 201 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 202 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 203 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 204 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 205 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 206 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 207 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 208 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 209 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 210 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 211 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 212 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 213 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 214 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 215 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 216 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 217 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 218 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 219 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 220 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 221 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 222 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 223 CHINA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 224 CHINA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 225 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 226 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 227 CHINA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 228 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 229 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 230 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 231 CHINA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 232 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 233 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 234 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 235 JAPAN: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 236 JAPAN: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 237 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 238 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 239 JAPAN: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 240 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 241 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 242 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 243 JAPAN: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 244 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 245 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 246 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 247 INDIA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 248 INDIA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 249 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 250 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 251 INDIA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 252 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 253 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 254 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 255 INDIA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 256 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 257 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 258 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 259 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 260 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 261 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 262 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 263 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 264 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 265 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 266 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 267 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 268 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 269 AUSTRALIA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 270 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 271 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 272 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 273 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 274 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 275 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 276 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 277 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 278 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 279 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 280 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 281 SOUTH KOREA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 282 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 283 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 284 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 285 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 286 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 287 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 288 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 289 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 290 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 291 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 292 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 293 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 294 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 295 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 296 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 297 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 298 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 299 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 300 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 301 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 302 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 303 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 304 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 305 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 306 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 307 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 308 BRAZIL: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 309 BRAZIL: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 310 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 311 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 312 BRAZIL: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 313 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 314 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 315 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 316 BRAZIL: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 317 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 318 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 319 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 320 MEXICO: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 321 MEXICO: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 322 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 323 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 324 MEXICO: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 325 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 326 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 327 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 328 MEXICO: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 329 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 330 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 331 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 332 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 333 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 334 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 335 REST OF LATAM: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 336 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 337 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 338 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 339 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 340 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 341 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 342 REST OF LATAM: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 343 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 344 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 345 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 346 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 347 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 348 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 349 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 350 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 351 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 352 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 353 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 354 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 355 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 356 GCC: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 357 GCC: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 358 GCC: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 359 GCC: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 360 GCC: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 361 GCC: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 362 GCC: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 363 GCC: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 364 GCC: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 365 GCC: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 366 GCC: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 367 GCC: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 368 GCC: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 369 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 370 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 371 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 372 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 373 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 374 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 375 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 376 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 377 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 378 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 379 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 380 SAUDI ARABIA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 381 UAE: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 382 UAE: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 383 UAE: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 384 UAE: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 385 UAE: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 386 UAE: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 387 UAE: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 388 UAE: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 389 UAE: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 390 UAE: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 391 UAE: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 392 UAE: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 393 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 394 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 395 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 396 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 397 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 398 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 399 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 400 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 401 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 402 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 403 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 404 REST OF GCC: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 405 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 406 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 407 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 408 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 409 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 410 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 411 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 412 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 413 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 414 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 415 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 416 SOUTH AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 417 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 418 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 419 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 420 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
  • TABLE 421 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 422 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 423 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
  • TABLE 424 REST OF MEA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2024-2031 (USD MILLION)
  • TABLE 425 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
  • TABLE 426 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 427 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 428 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 429 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN RADIATION DOSE MANAGEMENT MARKET, JANUARY 2023- AUGUST 2026
  • TABLE 430 RADIATION DOSE MANAGEMENT MARKET: DEGREE OF COMPETITION
  • TABLE 431 RADIATION DOSE MANAGEMENT MARKET: REGION FOOTPRINT
  • TABLE 432 RADIATION DOSE MANAGEMENT MARKET: OFFERING FOOTPRINT
  • TABLE 433 RADIATION DOSE MANAGEMENT MARKET: DEPLOYMENT MODEL FOOTPRINT
  • TABLE 434 RADIATION DOSE MANAGEMENT MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 435 RADIATION DOSE MANAGEMENT MARKET: LIST OF STARTUPS/SMES
  • TABLE 436 RADIATION DOSE MANAGEMENT MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 437 RADIATION DOSE MANAGEMENT: PRODUCT LAUNCHES AND UPGRADES (JANUARY 2023-JUNE 2026)
  • TABLE 438 RADIATION DOSE MANAGEMENT MARKET: DEALS (JANUARY 2023-JUNE 2026)
  • TABLE 439 RADIATION DOSE MANAGEMENT MARKET: OTHER DEVELOPMENTS (JANUARY 2023-JUNE 2026)
  • TABLE 440 BAYER AG: BUSINESS OVERVIEW
  • TABLE 441 BAYER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 442 BAYER AG: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
  • TABLE 443 BAYER AG: DEALS, JANUARY 2023-AUGUST 2026
  • TABLE 444 BAYER AG: OTHER DEVELOPMENTS, JANUARY 2023-AUGUST 2026
  • TABLE 445 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW
  • TABLE 446 SIEMENS HEALTHINEERS AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 447 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023- AUGUST 2026
  • TABLE 448 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2023- AUGUST 2026
  • TABLE 449 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2023-AUGUST 2026
  • TABLE 450 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
  • TABLE 451 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 452 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
  • TABLE 453 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023-AUGUST 2026
  • TABLE 454 GE HEALTHCARE: BUSINESS OVERVIEW
  • TABLE 455 GE HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 456 GE HEALTHCARE: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023- AUGUST 2026
  • TABLE 457 GE HEALTHCARE: DEALS, JANUARY 2023-AUGUST 2026
  • TABLE 458 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2023-AUGUST 2026
  • TABLE 459 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
  • TABLE 460 FUJIFILM HOLDINGS CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 461 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
  • TABLE 462 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2023-AUGUST 2026
  • TABLE 463 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023-AUGUST 2026
  • TABLE 464 SECTRA AB: BUSINESS OVERVIEW
  • TABLE 465 SECTRA AB: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 466 SECTRA AB: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023- AUGUST 2026
  • TABLE 467 SECTRA AB: DEALS, JANUARY 2023-AUGUST 2026
  • TABLE 468 SECTRA AB: OTHER DEVELOPMENTS, JANUARY 2023-AUGUST 2026
  • TABLE 469 CANON INC.: BUSINESS OVERVIEW
  • TABLE 470 CANON INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 471 CANON INC.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
  • TABLE 472 CANON INC.: DEALS, JANUARY 2023-AUGUST 2026
  • TABLE 473 CANON INC.: OTHER DEVELOPMENTS, JANUARY 2023-AUGUST 2026
  • TABLE 474 AGFA-GEVAERT N.V.: BUSINESS OVERVIEW
  • TABLE 475 AGFA-GEVAERT N.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 476 AGFA-GEVAERT N.V.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
  • TABLE 477 AGFA-GEVAERT N.V.: DEALS, JANUARY 2023-AUGUST 2026
  • TABLE 478 PACSHEALTH, LLC: BUSINESS OVERVIEW
  • TABLE 479 PACSHEALTH, LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 480 PACSHEALTH, LLC: DEALS, JANUARY 2023-AUGUST 2026
  • TABLE 481 QAELUM: BUSINESS OVERVIEW
  • TABLE 482 QAELUM: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 483 QAELUM: DEALS, JANUARY 2023-AUGUST 2026
  • TABLE 484 MEDSQUARE: BUSINESS OVERVIEW
  • TABLE 485 MEDSQUARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 486 MEDSQUARE: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
  • TABLE 487 MEDSQUARE: DEALS, JANUARY 2023-AUGUST 2026
  • TABLE 488 NOVARAD: BUSINESS OVERVIEW
  • TABLE 489 NOVARAD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 490 INFINITT HEALTHCARE CO., LTD.: BUSINESS OVERVIEW
  • TABLE 491 INFINITT HEALTHCARE CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 492 CARESTREAM HEALTH: BUSINESS OVERVIEW
  • TABLE 493 CARESTREAM HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 494 CARESTREAM HEALTH: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023- AUGUST 2026
  • TABLE 495 CARESTREAM HEALTH: DEALS, JANUARY 2023-AUGUST 2026
  • TABLE 496 SHIMADZU CORPORATION: BUSINESS OVERVIEW
  • TABLE 497 SHIMADZU CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 498 SHIMADZU CORPORATION: PRODUCTS LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
  • TABLE 499 SHIMADZU CORPORATION: DEALS, JANUARY 2023-AUGUST 2026
  • TABLE 500 NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.: BUSINESS OVERVIEW
  • TABLE 501 NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 502 NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
  • TABLE 503 NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.: DEALS, JANUARY 2023-AUGUST 2026
  • TABLE 504 NEUSOFT MEDICAL SYSTEMS CO., LTD.: BUSINESS OVERVIEW
  • TABLE 505 NEUSOFT MEDICAL SYSTEMS CO., LTD.: PRODUCTS/SOLUTIONS/ SERVICES OFFERED
  • TABLE 506 NEUSOFT MEDICAL SYSTEMS CO., LTD.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
  • TABLE 507 NEUSOFT MEDICAL SYSTEMS CO., LTD.: DEALS, JANUARY 2023-AUGUST 2026
  • TABLE 508 KONICA MINOLTA, INC.: BUSINESS OVERVIEW
  • TABLE 509 KONICA MINOLTA, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 510 KONICA MINOLTA, INC.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
  • TABLE 511 KONICA MINOLTA, INC.: DEALS, JANUARY 2023-AUGUST 2026
  • TABLE 512 IBA: BUSINESS OVERVIEW
  • TABLE 513 IBA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 514 IBA: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023-AUGUST 2026
  • TABLE 515 IBA: DEALS, JANUARY 2023-AUGUST 2026
  • TABLE 516 LUNIT INC.: BUSINESS OVERVIEW
  • TABLE 517 LUNIT INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 518 LUNIT INC.: DEALS, JANUARY 2023-AUGUST 2026
  • TABLE 519 RISK ASSESSMENT: RADIATION DOSE MANAGEMENT MARKET

List of Figures

  • FIGURE 1 RADIATION DOSE MANAGEMENT MARKET SEGMENTATION
  • FIGURE 2 MARKET SCENARIO
  • FIGURE 3 GLOBAL RADIATION DOSE MANAGEMENT MARKET, 2024-2031
  • FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN RADIATION DOSE MANAGEMENT MARKET, 2023-2026
  • FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF RADIATION DOSE MANAGEMENT MARKET
  • FIGURE 6 HIGH-GROWTH SEGMENTS IN RADIATION DOSE MANAGEMENT MARKET, 2026-2031
  • FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN RADIATION DOSE MANAGEMENT MARKET DURING FORECAST PERIOD
  • FIGURE 8 INCREASING ADOPTION OF ADVANCED DOSE MONITORING AND OPTIMIZATION SOLUTIONS TO DRIVE MARKET GROWTH
  • FIGURE 9 SOLUTIONS ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA IN 2025
  • FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 11 RADIATION DOSE MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 12 RADIATION DOSE MANAGEMENT MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 13 RADIATION DOSE MANAGEMENT MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 14 RADIATION DOSE MANAGEMENT MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 15 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR RADIATION DOSE MANAGEMENT MARKET
  • FIGURE 16 RECENT FUNDING OF SELECTED PLAYERS IN RDM MARKET
  • FIGURE 17 PATENT PUBLICATION TRENDS IN RADIATION DOSE MANAGEMENT MARKET, 2015-2026
  • FIGURE 18 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR RADIATION DOSE MANAGEMENT PATENTS, 2015-2026
  • FIGURE 19 RADIATION DOSE MANAGEMENT MARKET: TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR PATENTS (JANUARY 2015-AUGUST 2026)
  • FIGURE 20 POTENTIAL OF AI/GEN AI IN RADIATION DOSE MANAGEMENT MARKET
  • FIGURE 21 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
  • FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • FIGURE 23 RADIATION DOSE MANAGEMENT: KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 24 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET SNAPSHOT
  • FIGURE 25 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET SNAPSHOT
  • FIGURE 26 REVENUE SHARE ANALYSIS OF KEY PLAYERS
  • FIGURE 27 MARKET SHARE ANALYSIS, BY KEY PLAYER (2025)
  • FIGURE 28 RADIATION DOSE MANAGEMENT MARKET: BRAND COMPARISON
  • FIGURE 29 EV/EBITDA OF KEY VENDORS
  • FIGURE 30 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF VENDORS
  • FIGURE 31 RADIATION DOSE MANAGEMENT MARKET: KEY PLAYERS, 2025
  • FIGURE 32 RADIATION DOSE MANAGEMENT MARKET: COMPANY FOOTPRINT
  • FIGURE 33 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2025)
  • FIGURE 34 BAYER AG: COMPANY SNAPSHOT (2025)
  • FIGURE 35 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2025)
  • FIGURE 36 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025)
  • FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT (2025)
  • FIGURE 38 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2026)
  • FIGURE 39 SECTRA AB: COMPANY SNAPSHOT (2026)
  • FIGURE 40 CANON INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 41 AGFA-GEVAERT N.V.: COMPANY SNAPSHOT (2025)
  • FIGURE 42 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2026)
  • FIGURE 43 KONICA MINOLTA, INC.: COMPANY SNAPSHOT (2026)
  • FIGURE 44 IBA: COMPANY SNAPSHOT (2025)
  • FIGURE 45 LUNIT INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 46 RESEARCH DESIGN
  • FIGURE 47 PRIMARY SOURCES
  • FIGURE 48 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 49 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 50 BOTTOM-UP APPROACH
  • FIGURE 51 TOP-DOWN APPROACH
  • FIGURE 52 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 53 RADIATION DOSE MANAGEMENT MARKET: CAGR PROJECTION ANALYSIS
  • FIGURE 54 DATA TRIANGULATION METHODOLOGY
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!